|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| A61K 35/35 | |||
| A61K 8/64 | |||
| A61K 9/00 | |||
| A61Q 19/08 | |||
| A61P 17/02 | |||
| A61P 41/00 |
| (11) | Number of the document | 2539443 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11746961.9 |
| Date of filing the European patent application | 2011-02-23 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2011/000181 |
| Date | 2011-02-23 |
| (87) | Number | WO 2011/104707 |
| Date | 2011-09-01 |
| (30) | Number | Date | Country code |
| 306991 P | 2010-02-23 | US |
| (72) |
HAMED, Saher, IL
|
| (73) |
SEBANA MEDICAL LTD.,
Nazareth Industrial Area P.O.Box 1251, 17111 Nazareth IIit,
IL
|
| (54) | ERYTHROPOIETIN FOR USE IN ENHANCING FAT GRAFT SURVIVAL |
| ERYTHROPOIETIN FOR USE IN ENHANCING FAT GRAFT SURVIVAL |